Login

Balance sheets

In USD, except per-share amounts
Q1 FY2027
As of Jul 31, 2026
Q4 FY2026
As of Apr 30, 2026
Q3 FY2026
As of Jan 31, 2026
Q2 FY2026
As of Oct 31, 2025
Q1 FY2026
As of Jul 31, 2025
Q4 FY2025
As of Apr 30, 2025
Q3 FY2025
As of Jan 31, 2025
Q2 FY2025
As of Oct 31, 2024
Q1 FY2025
As of Jul 31, 2024
Q4 FY2024
As of Apr 30, 2024
Q3 FY2024
As of Jan 31, 2024
Q2 FY2024
As of Oct 31, 2023
Q1 FY2024
As of Jul 31, 2023
Q4 FY2023
As of Apr 30, 2023
Q3 FY2023
As of Jan 31, 2023
Q2 FY2023
As of Oct 31, 2022
Q1 FY2023
As of Jul 31, 2022
Cash on hand
Total Current Assets
Accumulated Depreciation
Mobile Application and Website Development
Total Non-Current Intangible Assets
Interest receivable
Total Assets
Interest Payable
Total Current Liabilities
Director Loan
Promissory Note
Total Long term Liabilities
Total Liabilities
Common stock, $0.0001 par value, 75,000,000 shares authorized; 5,495,300 shares issued and outstanding respectively
Additional paid-in-capital
Accumulated deficit
Total Stockholders’ Equity
Total Liabilities and Stockholders’ Equity

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support